Fine-tuned continuous renal replacement therapy with calcium-free dialysate to manage severe hypercalcemia refractory to medical and intermittent hemodialysis

Abstract Malignancy-related hypercalcemia is a leading cause of hypercalcemia among hospitalized patients that carries poor prognosis. Parathyroid carcinoma is a rare form of primary hyperparathyroidism that may be associated with PTH dependent hypercalcemia. Severe hypercalcemia is life-threatening...

Full description

Bibliographic Details
Main Authors: Marc Scheen, Grzegorz Nowak, Bienvenido Sanchez, Daniel Teta
Format: Article
Language:English
Published: BMC 2022-06-01
Series:European Journal of Medical Research
Online Access:https://doi.org/10.1186/s40001-022-00715-x
_version_ 1811251512882495488
author Marc Scheen
Grzegorz Nowak
Bienvenido Sanchez
Daniel Teta
author_facet Marc Scheen
Grzegorz Nowak
Bienvenido Sanchez
Daniel Teta
author_sort Marc Scheen
collection DOAJ
description Abstract Malignancy-related hypercalcemia is a leading cause of hypercalcemia among hospitalized patients that carries poor prognosis. Parathyroid carcinoma is a rare form of primary hyperparathyroidism that may be associated with PTH dependent hypercalcemia. Severe hypercalcemia is life-threatening and may require management in an intensive care unit by means of medical therapy consisting of volume expansion, loop diuretics, cinacalcet, calcitonin and bisphosphonates. Renal replacement therapy such as intermittent hemodialysis has been successfully used among patients with severe hypercalcemia who become refractory to medical treatment. However, little data are available for cases of severe refractory hypercalcemia that fail to respond to both optimal medical therapy and hemodialysis. Our present case illustrates the successful use of continuous veno-venous hemodiafiltration (CVVHDF) with calcium-free dialysate calcium and markedly increased dialysate flow rate, to restore normal calcemia in a patient with metastatic parathyroid carcinoma with severe refractory hypercalcemia.
first_indexed 2024-04-12T16:20:33Z
format Article
id doaj.art-f86180a353644ce2866798a479205dfb
institution Directory Open Access Journal
issn 2047-783X
language English
last_indexed 2024-04-12T16:20:33Z
publishDate 2022-06-01
publisher BMC
record_format Article
series European Journal of Medical Research
spelling doaj.art-f86180a353644ce2866798a479205dfb2022-12-22T03:25:34ZengBMCEuropean Journal of Medical Research2047-783X2022-06-012711410.1186/s40001-022-00715-xFine-tuned continuous renal replacement therapy with calcium-free dialysate to manage severe hypercalcemia refractory to medical and intermittent hemodialysisMarc Scheen0Grzegorz Nowak1Bienvenido Sanchez2Daniel Teta3Service of Nephrology, Hôpital du ValaisService of Nephrology, Hôpital du ValaisService of Intensive Care Medicine, Hôpital du ValaisService of Nephrology, Hôpital du ValaisAbstract Malignancy-related hypercalcemia is a leading cause of hypercalcemia among hospitalized patients that carries poor prognosis. Parathyroid carcinoma is a rare form of primary hyperparathyroidism that may be associated with PTH dependent hypercalcemia. Severe hypercalcemia is life-threatening and may require management in an intensive care unit by means of medical therapy consisting of volume expansion, loop diuretics, cinacalcet, calcitonin and bisphosphonates. Renal replacement therapy such as intermittent hemodialysis has been successfully used among patients with severe hypercalcemia who become refractory to medical treatment. However, little data are available for cases of severe refractory hypercalcemia that fail to respond to both optimal medical therapy and hemodialysis. Our present case illustrates the successful use of continuous veno-venous hemodiafiltration (CVVHDF) with calcium-free dialysate calcium and markedly increased dialysate flow rate, to restore normal calcemia in a patient with metastatic parathyroid carcinoma with severe refractory hypercalcemia.https://doi.org/10.1186/s40001-022-00715-x
spellingShingle Marc Scheen
Grzegorz Nowak
Bienvenido Sanchez
Daniel Teta
Fine-tuned continuous renal replacement therapy with calcium-free dialysate to manage severe hypercalcemia refractory to medical and intermittent hemodialysis
European Journal of Medical Research
title Fine-tuned continuous renal replacement therapy with calcium-free dialysate to manage severe hypercalcemia refractory to medical and intermittent hemodialysis
title_full Fine-tuned continuous renal replacement therapy with calcium-free dialysate to manage severe hypercalcemia refractory to medical and intermittent hemodialysis
title_fullStr Fine-tuned continuous renal replacement therapy with calcium-free dialysate to manage severe hypercalcemia refractory to medical and intermittent hemodialysis
title_full_unstemmed Fine-tuned continuous renal replacement therapy with calcium-free dialysate to manage severe hypercalcemia refractory to medical and intermittent hemodialysis
title_short Fine-tuned continuous renal replacement therapy with calcium-free dialysate to manage severe hypercalcemia refractory to medical and intermittent hemodialysis
title_sort fine tuned continuous renal replacement therapy with calcium free dialysate to manage severe hypercalcemia refractory to medical and intermittent hemodialysis
url https://doi.org/10.1186/s40001-022-00715-x
work_keys_str_mv AT marcscheen finetunedcontinuousrenalreplacementtherapywithcalciumfreedialysatetomanageseverehypercalcemiarefractorytomedicalandintermittenthemodialysis
AT grzegorznowak finetunedcontinuousrenalreplacementtherapywithcalciumfreedialysatetomanageseverehypercalcemiarefractorytomedicalandintermittenthemodialysis
AT bienvenidosanchez finetunedcontinuousrenalreplacementtherapywithcalciumfreedialysatetomanageseverehypercalcemiarefractorytomedicalandintermittenthemodialysis
AT danielteta finetunedcontinuousrenalreplacementtherapywithcalciumfreedialysatetomanageseverehypercalcemiarefractorytomedicalandintermittenthemodialysis